Investors likely don't give much of a thought to packaging companies, unless it is to consider the ramifications of scare-stories like the presence of bisphenol A (BPA) in food cans. After all, this is just a commodity business with low growth potential, right?

Well, maybe not. It's absolutely true that packaging is not exciting from a growth perspective, but there is a lot to be said for an industry with customer-supplier relationships measured in decades of years, consistent margins and cash flow and consolidation potential. With that in mind, the deal between
Silgan (Nasdaq:SLGN) and Graham Packaging (NYSE:GRM) becomes a little more interesting.

Tutorial: The Basics Of Mergers And Acquisitions

Terms of the Deal
Silgan has long been an active acquirer, doing over 25 deals in the last 25 years, but Wednesday's deal for Graham is a whopper by past standards. Silgan is acquiring this plastic packaging specialist in a deal worth $4.1 billion based upon the pre-deal values of the respective stocks.

Silgan is paying considerations valued at $19.56 per share (again, based on Tuesday's closing prices), a 17% premium to Graham's prior close. Silgan is offering shareholders a mix of compensation - $4.75 in straight-up cash and 0.402 shares of Silgan stock. Because of that sizable chunk of stock, the real value of the deal is going to move around prior to the close of the deal. (For more, see Mergers And Acquisitions: Understanding Takeovers.)

What Silgan Is Getting
Acquiring Graham is all about folding in a quality player in the plastic packaging space. Silgan is a major player in metal food cans, boasting long relationships with major food companies like Campbell (NYSE:CPB), Nestle (Nasdaq:NSRGY) and Del Monte (NYSE:DLM). Silgan also does have a closures business and a plastic containers business, but Graham is going to increase the scale of that latter business considerably.

Like Silgan, Graham is largely focused on the food (and beverage) markets - getting more than 60% of its revenue from food clients like PepsiCo (NYSE:PEP), Coca-Cola (NYSE: KO) and Danone. In fact, Graham is a market leader in many of its businesses, including packages for yogurt products.

There should be good synergy in this deal, though, as most of Silgan's plastics business is in personal care products (lotions, shampoo, etc.), while that is a smaller business for Graham. So not only does this bring new customers to Silgan, it gives them the chance to sell more product to existing customers and potentially displace rivals like Ball (NYSE:BLL) and Amcor.

Should Investors Open This Up?
Silgan has posted shockingly consistent operating margins over the years, with an attractive upward trend. Likewise, revenue growth has been pretty consistent over the course of time. This deal would not seem to imperil any of that, and should give the company the opportunity to wring some cost-cutting benefits out of the combined systems. (For more, see Analyzing Operating Margins.)

Much as it seems like a cheap-shot to invoke Warren Buffett and Berkshire Hathaway (NYSE:BRK.A) when discussing value ideas, I have to say that there seem to be some Buffett-ish qualities to this name. It's a dull business, but it is a reliable one that is relatively easy to understand and this acquisition of Graham should help mitigate the risks Silgan faces from migrations away from metal containers. Likewise, it is a consistent cash flow generator that could likely benefit from cheap capital. That, and the exposure to commodity inputs makes it seem not too dissimilar to business like floor care and building materials, areas where Buffett has made large purchases in the past.

The Bottom Line
Figuring the additional cash flow and subtracting the dilution from extra shares and debt, this looks like a value-additive deal. Wall Street would seem to agree, as Silgan's shares are up over 10%, and that's not too common with premium buyout deals. What's more, Silgan shares look cheap enough to be worth a serious look. This is no doubt a dull, low-growth industry but value is value and this could be a stock that pays patient investors to wait. (For more, see The Value Investor's Handbook.)

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

Related Articles
  1. Investing

    Time to Bring Active Back into a Portfolio?

    While stocks have rallied since the economic recovery in 2009, many active portfolio managers have struggled to deliver investor returns in excess.
  2. Economics

    Investing Opportunities as Central Banks Diverge

    After the Paris attacks investors are focusing on central bank policy and its potential for divergence: tightened by the Fed while the ECB pursues easing.
  3. Stock Analysis

    The Biggest Risks of Investing in Pfizer Stock

    Learn the biggest potential risks that may affect the price of Pfizer's stock, complete with a fundamental analysis and review of other external factors.
  4. Stock Analysis

    Allstate: How Being Boring Earns it Billions (ALL)

    A summary of what Allstate Insurance sells and whom it sells it to including recent mergers and acquisitions that have helped boost its bottom line.
  5. Options & Futures

    Cyclical Versus Non-Cyclical Stocks

    Investing during an economic downturn simply means changing your focus. Discover the benefits of defensive stocks.
  6. Markets

    PEG Ratio Nails Down Value Stocks

    Learn how this simple calculation can help you determine a stock's earnings potential.
  7. Stock Analysis

    What Exactly Does Warren Buffett Own?

    Learn about large changes to Berkshire Hathaway's portfolio. See why Warren Buffett has invested in a commodity company even though he does not usually do so.
  8. Investing Basics

    How to Deduct Your Stock Losses

    Held onto a stock for too long? Selling at a loss is never ideal, but it is possible to minimize the damage. Here's how.
  9. Investing

    What’s the Difference Between Duration & Maturity?

    We look at the meaning of two terms that often get confused, duration and maturity, to set the record straight.
  10. Economics

    Is Wall Street Living in Denial?

    Will remaining calm and staying long present significant risks to your investment health?
  1. What does low working capital say about a company's financial prospects?

    When a company has low working capital, it can mean one of two things. In most cases, low working capital means the business ... Read Full Answer >>
  2. Do nonprofit organizations have working capital?

    Nonprofit organizations continuously face debate over how much money they bring in that is kept in reserve. These financial ... Read Full Answer >>
  3. Can a company's working capital turnover ratio be negative?

    A company's working capital turnover ratio can be negative when a company's current liabilities exceed its current assets. ... Read Full Answer >>
  4. Does working capital measure liquidity?

    Working capital is a commonly used metric, not only for a company’s liquidity but also for its operational efficiency and ... Read Full Answer >>
  5. How do I read and analyze an income statement?

    The income statement, also known as the profit and loss (P&L) statement, is the financial statement that depicts the ... Read Full Answer >>
  6. Can working capital be too high?

    A company's working capital ratio can be too high in the sense that an excessively high ratio is generally considered an ... Read Full Answer >>

You May Also Like

Trading Center